• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

• 药品评价-临床研究 • 上一篇    下一篇

青蒿素类药物的主要研究进展述评

张楠   

  1. 中国科协发展研究中心
  • 收稿日期:2013-02-26 修回日期:2013-02-26 出版日期:2013-02-25 发布日期:2013-01-25

Research Progress of the Artemisinin Drugs

ZHANG Nan   

  1. rhrtadfjtjs
  • Received:2013-02-26 Revised:2013-02-26 Online:2013-02-25 Published:2013-01-25

摘要: 青蒿素是从我国中草药成分里通过化学提炼开发出的有价值药物成分,在治疗疟疾方面取得世界瞩目的成绩。鉴于世界卫生组织已开始重视疟原虫耐药性的严重性,青蒿素类药物在其他领域的临床应用开发显得尤为重要:包括抗寄生虫、抗肿瘤、抗孕等方面的预防和治疗进展,将为其今后的发展前景带来新思路。

Abstract: Artemisinin is produced by the Chinese medicinal herb Artemisia annual, and achieved world-noted achievements in the treatment of malaria. Due to World Health Organization has already pay attention to the antimalarial drug efficacy and drug resistance,artemisinin drugs in other areas of clinical application development is very important: such as anti parasite, anti tumor, anti pregnancy and so on.In the future, the development prospects of new ideas can be found,